Literature DB >> 3796616

Tyrosyl kinase activity is inversely related to prostatic acid phosphatase activity in two human prostate carcinoma cell lines.

M F Lin, C L Lee, G M Clinton.   

Abstract

Alterations in prostatic acid phosphatase (PAcP), a phosphotyrosyl phosphatase, corresponded to changes in overall tyrosyl kinase activity. PAcP added to extracts of prostate carcinoma cells with a low endogenous level of PAcP activity and elevated tyrosyl kinase activity decreased the tyrosyl kinase activity. On the other hand, when PAcP activity was decreased by the addition of androgens to cells, there was a corresponding increase in tyrosyl kinase activity.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3796616      PMCID： PMC367263          DOI： 10.1128/mcb.6.12.4753-4757.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN： 0270-7306            Impact factor:   4.272


  29 in total

Review 1.  Clinical significance of the human acid phosphatases: a review.

Authors:  L T Yam
Journal:  Am J Med       Date:  1974-05       Impact factor: 4.965

2.  Purification and characterization of a new human prostatic acid phosphatase isoenzyme.

Authors:  M F Lin; C L Lee; S S Li; T M Chu
Journal:  Biochemistry       Date:  1983-03-01       Impact factor: 3.162

3.  In vitro phosphorylation of angiotensin analogs by tyrosyl protein kinases.

Authors:  T W Wong; A R Goldberg
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

4.  The LNCaP cell line--a new model for studies on human prostatic carcinoma.

Authors:  J S Horoszewicz; S S Leong; T M Chu; Z L Wajsman; M Friedman; L Papsidero; U Kim; L S Chai; S Kakati; S K Arya; A A Sandberg
Journal:  Prog Clin Biol Res       Date:  1980

5.  Human prostatic acid phosphatase has phosphotyrosyl protein phosphatase activity.

Authors:  M F Lin; G M Clinton
Journal:  Biochem J       Date:  1986-04-15       Impact factor: 3.857

6.  Comparison of prostatic and nonprostatic acid phosphatase.

Authors:  K W Lam; C Y Li; L T Yam; R S Smith; B Hacker
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

7.  Phosphorylation activates the insulin receptor tyrosine protein kinase.

Authors:  O M Rosen; R Herrera; Y Olowe; L M Petruzzelli; M H Cobb
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

8.  Expression of prostatic acid phosphatase in human prostate cancer.

Authors:  R Loor; M C Wang; L Valenzuela; T M Chu
Journal:  Cancer Lett       Date:  1981-10       Impact factor: 8.679

9.  Glycoprotein exhibiting immunological and enzymatic activities of human prostatic acid phosphatase.

Authors:  M F Lin; C L Lee; F S Sharief; S S Li; T M Chu
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

10.  LNCaP model of human prostatic carcinoma.

Authors:  J S Horoszewicz; S S Leong; E Kawinski; J P Karr; H Rosenthal; T M Chu; E A Mirand; G P Murphy
Journal:  Cancer Res       Date:  1983-04       Impact factor: 12.701
View more
  5 in total

1.  Human prostatic acid phosphatase, an authentic tyrosine phosphatase, dephosphorylates ErbB-2 and regulates prostate cancer cell growth.

Authors:  Tsai-Der Chuang; Siu-Ju Chen; Fen-Fen Lin; Suresh Veeramani; Satyendra Kumar; Surinder K Batra; Yaping Tu; Ming-Fong Lin
Journal:  J Biol Chem       Date:  2010-05-24       Impact factor: 5.157

2.  Transcriptional activation of the human prostatic acid phosphatase gene by NF-kappaB via a novel hexanucleotide-binding site.

Authors:  Stanislav Zelivianski; Richard Glowacki; Ming-Fong Lin
Journal:  Nucleic Acids Res       Date:  2004-07-07       Impact factor: 16.971

3.  The epidermal growth factor receptor from prostate cells is dephosphorylated by a prostate-specific phosphotyrosyl phosphatase.

Authors:  M F Lin; G M Clinton
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

4.  Reactive oxygen species induced by p66Shc longevity protein mediate nongenomic androgen action via tyrosine phosphorylation signaling to enhance tumorigenicity of prostate cancer cells.

Authors:  Suresh Veeramani; Yu-Wei Chou; Frank C Lin; Sakthivel Muniyan; Fen-Fen Lin; Satyendra Kumar; Yan Xie; Subodh M Lele; Yaping Tu; Ming-Fong Lin
Journal:  Free Radic Biol Med       Date:  2012-04-16       Impact factor: 7.376

5.  Androgens upregulate Cdc25C protein by inhibiting its proteasomal and lysosomal degradation pathways.

Authors:  Yu-Wei Chou; Li Zhang; Sakthivel Muniyan; Humera Ahmad; Satyendra Kumar; Syed Mahfuzul Alam; Ming-Fong Lin
Journal:  PLoS One       Date:  2013-04-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.